These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 15888665

  • 21. Biochemical effects of low level exposure to soman vapour.
    Bajgar J, Sevelová L, Krejcová G, Fusek J, Vachek J, Kassa J, Herink J, de Jong LP, Benschop H.
    Cent Eur J Public Health; 2004 Mar; 12 Suppl():S4-7. PubMed ID: 15141961
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Research into selective biomarkers of erythrocyte exposure to organophosphorus compounds.
    Aminoff D, Bochar DA, Fuller AA, Mapp AK, Showalter HD, Kirchhoff PD.
    Anal Biochem; 2009 Sep 15; 392(2):155-61. PubMed ID: 19497294
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Bioscavengers for the protection of humans against organophosphate toxicity.
    Doctor BP, Saxena A.
    Chem Biol Interact; 2005 Dec 15; 157-158():167-71. PubMed ID: 16293236
    [Abstract] [Full Text] [Related]

  • 27. Each lipase has a unique sensitivity profile for organophosphorus inhibitors.
    Quistad GB, Liang SN, Fisher KJ, Nomura DK, Casida JE.
    Toxicol Sci; 2006 May 15; 91(1):166-72. PubMed ID: 16449251
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Subacute neurotoxicity induced in mice by potent organophosphorus neuropathy target esterase inhibitors.
    Wu SY, Casida JE.
    Toxicol Appl Pharmacol; 1996 Jul 15; 139(1):195-202. PubMed ID: 8685903
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A murine model for sarin exposure using the carboxylesterase inhibitor CBDP.
    Garrett TL, Rapp CM, Grubbs RD, Schlager JJ, Lucot JB.
    Neurotoxicology; 2010 Sep 15; 31(5):502-8. PubMed ID: 20510297
    [Abstract] [Full Text] [Related]

  • 37. Interaction of pentylsarin analogues with human acetylcholinesterase: a kinetic study.
    Worek F, Herkert NM, Koller M, Aurbek N, Thiermann H.
    Toxicol Lett; 2009 Jun 01; 187(2):119-23. PubMed ID: 19429253
    [Abstract] [Full Text] [Related]

  • 38. Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effect of tiapride.
    Petroianu GA, Hasan MY, Arafat K, Nurulain SM, Schmitt A.
    J Appl Toxicol; 2005 Jun 01; 25(6):562-7. PubMed ID: 16193528
    [Abstract] [Full Text] [Related]

  • 39. Differential mRNA expression of acetylcholinesterase in the central nervous system of rats with acute and chronic exposure of sarin & physostigmine.
    Bansal I, Waghmare CK, Anand T, Gupta AK, Bhattacharya BK.
    J Appl Toxicol; 2009 Jul 01; 29(5):386-94. PubMed ID: 19283689
    [Abstract] [Full Text] [Related]

  • 40. Lysophosphatidylcholine hydrolases of human erythrocytes, lymphocytes, and brain: sensitive targets of conserved specificity for organophosphorus delayed neurotoxicants.
    Vose SC, Holland NT, Eskenazi B, Casida JE.
    Toxicol Appl Pharmacol; 2007 Oct 01; 224(1):98-104. PubMed ID: 17663017
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.